The interferon system as a basis for antiviral therapy or prophylaxis
Billiau, A.
Verhandelingen - Koninklijke Academie Voor Geneeskunde van Belgie 48(3): 187-220
1986
ISSN/ISBN: 0302-6469 PMID: 2430375 Document Number: 283228
Document emailed within 1 workday
Related Documents
Kirchner, H.; Chmielarczyk, W.; Storch, E.; Schindler, L. 1984: Antiviral effects of Corynebacterium parvum and its effect on the interferon system in mice Behring Institute Mitteilungen 74: 183-188Kasparov, A.A. 1972: The significance of interferon inductors in current antiviral therapy for herpetic eye disease Vestnik Oftalmologii 2: 63-67
de Artaza, T.; Sánchez, J.J.; González, C.; Pérez-Grueso, M.J.; Repiso, A.; Gómez, R.; Potenciano, J.L.M. 2004: Peripheral facial paralysis during interferon treatment in hepatitis C: recovery without antiviral therapy withdrawal Gastroenterologia y Hepatologia 27(7): 434-435
Fedorchenko, S.V. 1994: Can chronic hepatitis B patients overcome resistance to antiviral therapy due to production of antibodies to recombinant alpha-2-interferon? Voprosy Virusologii 39(5): 218-220
Tazulakhova, E.B.; Amitina, N.N.; Ershov, F.I. 1985: Interferon-inducing and antiviral effects of inosiplex in combination with high-molecular interferon inducers Biulleten' Eksperimental'noi Biologii i Meditsiny 100(10): 457-459
Cornella, C.; Torazza, M.C.; Strippoli, G.F.M.; Segoloni, G. 2007: Antiviral prophylaxis and pre-emptive therapy for the prevention of Cytomegalovirus infection in renal transplant recipients: guideline from the Italian Society of Nephrology Giornale Italiano di Nefrologia: Organo Ufficiale Della Societa Italiana di Nefrologia 24 Suppl. 37: S165-S178
Loginova, S.I.; Borisevich, S.V.; Maksimov, V.A.; Bondarev, V.P. 2009: Toxicity estimation of unspecific medicinal antiviral agents for prophylaxis and therapy of hazard and especially hazard viral infections Antibiotiki i Khimioterapiia 54(3-4): 11-14
Van Damme, J.; De Ley, M.; Van Snick, J.; Dinarello, C.A.; Billiau, A. 1987: The role of interferon-beta 1 and the 26-kDa protein (interferon-beta 2) as mediators of the antiviral effect of interleukin 1 and tumor necrosis factor Journal of Immunology 139(6): 1867-1872
Onwudiwe, O.C.; Marmur, E.S.; Cohen, J.L. 2013: Are we too cavalier about antiviral prophylaxis? Journal of Drugs in Dermatology: Jdd 12(2): 199-205
Inglot, A.D. 1980: Interferon as an antiviral, antineoplastic and immunomodulating agent Postepy Higieny i Medycyny Doswiadczalnej 34(2): 89-105
Shved, A.D. 1982: Antiviral properties of polynucleotides not associated with interferon induction Mikrobiolohichnyi Zhurnal 44(3): 75-85
Hull, C.; Spruance, S. 2007: Situational antiviral drug prophylaxis for HSV type 1 recurrences Herpes: the Journal of the Ihmf 14(2): 37-40
Wall, S.H.; Ramey, S.J.; Wall, F. 1999: Famciclovir as antiviral prophylaxis in laser resurfacing procedures Plastic and Reconstructive Surgery 104(4): 1103-1108; Discussion 1109
Constantinescu, S.N.; Cernescu, C.; Baltă, F.; Popescu, L.M. 1989: Interferon: signal molecules involved in its antiviral effect Virologie 40(2): 133-146
Cernescu, C.; Constantinescu, S.N.; Baltă, F.; Popescu, L.M.; Cajal, N. 1989: Protein kinase C and the antiviral effect of human interferon Virologie 40(3): 163-170
Takehara, M. 1975: Studies on interferon induction and antiviral activity by certain arboviruses Kobe Journal of Medical Sciences 21(1): 23-32
Wleklik, M.; Panasiak, W.; Luczak, M.; Konopińska, D. 1988: Tuftsin a natural peptide with antiviral activity--structural basis of its action Acta Virologica 32(1): 79-82
Wleklik, M.; Luczak, M.; Panasiak, W.; Kobus, M.; Lammer-Zarawska, E. 1988: Structural basis for antiviral activity of flavonoids-naturally occurring compounds Acta Virologica 32(6): 522-525
Ershov, F.I.; Sokolova, T.M.; Tazulakhova, E.B.; Kadyrova, A.A.; Kisling, U.; Novokhatsky, A.S. 1979: Comparative analysis of interferon and antiviral protein messenger RNAs Acta Virologica 23(1): 32-39
Nosik, N.N.; Pugachev, V.G.; Ershov, F.I. 1990: Double-stranded RNA from phage F6: its interferon-inducing and antiviral properties Antibiotiki i Khimioterapiia 35(3): 25-27